C57BL/6JCya-Smn1em1flox/Cya
Common Name:
Smn1-flox
Product ID:
S-CKO-05136
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Smn1-flox
Strain ID
CKOCMP-20595-Smn1-B6J-VA
Gene Name
Product ID
S-CKO-05136
Gene Alias
Gemin1; Smn
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
13
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Smn1em1flox/Cya mice (Catalog S-CKO-05136) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000022147
NCBI RefSeq
NM_011420
Target Region
Exon 2~5
Size of Effective Region
~2.5 kb
Detailed Document
Overview of Gene Research
Smn1, or survival motor neuron 1, is a gene of great significance. Its encoded protein, SMN, is ubiquitously expressed and is essential for the development and survival of motor neurons [6]. Spinal muscular atrophy (SMA), a leading cause of early infant death [1,2,3,4,5,6,7,8,9,10], is caused by bi-allelic mutations of Smn1 [1].
In SMA, loss or deletion of Smn1 leads to the insufficiency of the SMN protein, resulting in irreversible degeneration of lower motor neurons, muscle atrophy, and weakness [9]. The gene has a paralog, Smn2, which has variable copy numbers across populations along with Smn1. Sequence analysis of Smn1 is challenging due to its high similarity with Smn2 [1]. In about 96% of SMA patients, mutations in Smn1 are observed, with most showing homozygous absence of exons 7 and 8 or exon 7 only in Smn1 [3].
In conclusion, Smn1 is crucial for motor neuron development and survival. Its loss or mutation is the main cause of SMA. Understanding Smn1 through research helps in comprehending the molecular pathogenesis of SMA, which is essential for developing effective therapeutic strategies for this severe neurodegenerative disease [3,6,8,9].
References:
1. Chen, Xiao, Harting, John, Farrow, Emily, Pastinen, Tomi, Eberle, Michael A. 2023. Comprehensive SMN1 and SMN2 profiling for spinal muscular atrophy analysis using long-read PacBio HiFi sequencing. In American journal of human genetics, 110, 240-250. doi:10.1016/j.ajhg.2023.01.001. https://pubmed.ncbi.nlm.nih.gov/36669496/
2. Butchbach, Matthew E R. 2021. Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development. In International journal of molecular sciences, 22, . doi:10.3390/ijms22157896. https://pubmed.ncbi.nlm.nih.gov/34360669/
3. Wirth, B. . An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). In Human mutation, 15, 228-37. doi:. https://pubmed.ncbi.nlm.nih.gov/10679938/
4. Kolb, Stephen J, Kissel, John T. . Spinal Muscular Atrophy. In Neurologic clinics, 33, 831-46. doi:10.1016/j.ncl.2015.07.004. https://pubmed.ncbi.nlm.nih.gov/26515624/
5. Nishio, Hisahide, Niba, Emma Tabe Eko, Saito, Toshio, Takeshima, Yasuhiro, Awano, Hiroyuki. 2023. Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment. In International journal of molecular sciences, 24, . doi:10.3390/ijms241511939. https://pubmed.ncbi.nlm.nih.gov/37569314/
6. Reilly, Aoife, Chehade, Lucia, Kothary, Rashmi. 2022. Curing SMA: Are we there yet? In Gene therapy, 30, 8-17. doi:10.1038/s41434-022-00349-y. https://pubmed.ncbi.nlm.nih.gov/35614235/
7. Arnold, W David, Kassar, Darine, Kissel, John T. 2014. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. In Muscle & nerve, 51, 157-67. doi:10.1002/mus.24497. https://pubmed.ncbi.nlm.nih.gov/25346245/
8. Lunn, Mitchell R, Wang, Ching H. . Spinal muscular atrophy. In Lancet (London, England), 371, 2120-33. doi:10.1016/S0140-6736(08)60921-6. https://pubmed.ncbi.nlm.nih.gov/18572081/
9. Gowda, Vasantha Lakshmi, Fernandez-Garcia, Miguel A, Jungbluth, Heinz, Wraige, Elizabeth. 2022. New treatments in spinal muscular atrophy. In Archives of disease in childhood, 108, 511-517. doi:10.1136/archdischild-2021-323605. https://pubmed.ncbi.nlm.nih.gov/36316089/
10. Ogbonmide, Tolu, Rathore, Rajni, Rangrej, Shahid B, Carvalho, Victoria, Kelly, Irenaissia. 2023. Gene Therapy for Spinal Muscular Atrophy (SMA): A Review of Current Challenges and Safety Considerations for Onasemnogene Abeparvovec (Zolgensma). In Cureus, 15, e36197. doi:10.7759/cureus.36197. https://pubmed.ncbi.nlm.nih.gov/37065340/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen